Pages
Products
Inactivated Influenza A H1N1pdm [A/California/07/09]

Inactivated Influenza A H1N1pdm [A/California/07/09]

Cat.No. :  VNV-020

Storage:  -80°C Shipping:  Dry ice

Inquire for Price

Product Infomation

Cat. No. VNV-020
Description Wild type influenza A H1N1pdm [A/California/07/09] particles which are inactivated by heat treatment. This product is intended for research use only.
Shipping Dry ice
Storage -80°C
Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots.
Mycoplasma Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination.
Purity Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards.
Sterility The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities.
Proviral Identity Confirmation All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert.
Quick Inquiry

Case Study

Publications

Q & A

Customer Reviews

The global incidence of type 1 diabetes (T1D) is rapidly increasing, suggesting that environmental factors play an important role in its etiology. Several studies have implicated viral infections as a possible cause of T1D, including enteroviruses such as coxsackievirus B, measles, congenital rubella, mumps, cytomegalovirus, and influenza B. A report from a large Norwegian cohort showed an increased risk of T1D after infection with H1N1pdm. Here, researchers show that human H1N1 A/California/2009-derived viruses infect human islets in vitro, inducing a proinflammatory response accompanied by a substantial increase in CXCL9 and CXCL10 release. In vivo, infected mice displayed a marked susceptibility to the virus, with localization also found in extrapulmonary organs, including the pancreas. Infection was able to induce mild changes in blood glucose in C57B6 mice after chemical injury of the islets, but did not modulate autoimmune damage to islets in NOD mice. Studies have shown that influenza H1N1pdm strains are able to infect and replicate in mammalian pancreatic cells in vitro and in vivo but do not cause any functional impairments consistent with diabetes.

Here, the susceptibility of primary mouse islet cells and the MIN6 insulinoma cell line to infection with the mouse-adapted H1N1 pdm was investigated. Receptor detection using lectin staining for both cell sources revealed a high abundance of α-2,6 sialic acid-linked sialic acid molecules and α-2,3 linked residues (Figure 1A). In situ hybridization clearly demonstrated the presence of viral RNA within cells 4 days after viral infection (Figure 1B). Colocalization between viral and insulin RNA in dispersed mouse islet cells indicated that primary mouse β cells were susceptible to infection. Visual inspection of infected cells by light microscopy, cell recovery, and live/dead assays revealed no obvious cytopathic effects at any time post-infection (days 0 to 4; Figure 1C). Two groups of mice (nine per group) were infected with 106 TCID50/50 μL of mouse-adapted H1N1pdm virus by IN (light anesthesia) and IP routes, respectively. A third group of mice (IPin) of 6 mice were inoculated with inactivated mouse-adapted H1N1pdm virus by IP route to assess the absence of viral replication (Figure 1D). Three to five days later, RNA for the viral M gene was detected by (r)RT-PCR in the lungs and pancreas of 9 of 9 mice and 3 of 9 mice infected by IN route, respectively. In addition, 8 of 9 mice infected by IP route were positive for the viral M gene in both pancreas and lung.

Susceptibility of mouse to H1N1 pdm mouse-adapted virus.Figure 1. Susceptibility of mouse to H1N1 pdm mouse-adapted virus. (Capua I, et al., 2018)

Customer Q&As
What is the virology of Influenza A H1N1?

A: In virology, influenza A virus subtype H1N1 is an orthomyxovirus that contains the glycoproteins hemagglutinin (H) and neuraminidase (N). Hemagglutinin causes red blood cells to clump together and bind viruses to infected cells. Neuraminidase is a glycoside hydrolase that helps move viral particles through infected cells and assists in budding from host cells.

Is influenza A H1N1 contagious?

A: People infected with the H1N1 influenza virus should be considered potentially contagious as long as they are symptomatic and potentially contagious within 7 days of illness onset.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction